How Life Sciences Companies Can Optimize Their Supply Chains
This article covers the key areas life sciences companies should focus on to tighten their supply chain operations and reduce their exposure to disruption.
Learn More
Supporting biotech, diagnostic, medical device, and pharma companies from discovery to market – so your team can focus on the science.
You’re leading a company that could change lives through breakthrough therapies or revolutionary diagnostic tools. Your scientists are doing remarkable work in the lab, your clinical teams are navigating FDA pathways with precision, yet you’re spending hours each week on financial and compliance distractions:
This tension defines the modern life sciences landscape, where regulatory requirements grow more intricate even as funding becomes more selective, where investors demand greater transparency at earlier stages, and where tax regulations shift constantly around research expenses and international operations.
The life sciences sector operates under financial pressures that few other industries face, with companies burning through hundreds of millions in R&D before generating a single dollar of revenue, clinical trials that take years, and the constant threat that a single regulatory setback could erase years of progress and require immediate capital strategy adjustments.
At the same time, you’re managing the complexities of tax reporting for research expenses, managing international transfer pricing as you expand globally, and structuring equity compensation packages that help you compete for top scientific talent.
Rather than offering disconnected services, BPM provides integrated support that addresses the interconnected financial challenges life sciences companies face.
Our assurance professionals understand how to evaluate inventory in pre-commercial biotech companies, assess accruals for research activities, and audit revenue when licensing agreements contain multiple performance obligations spread across years.
We help you identify and substantiate R&D tax credits, structure international operations to optimize your global tax position, and implement transfer pricing policies that withstand scrutiny. Our Section 382 studies help you understand limitations on NOL utilization after capital raises or ownership changes.
Our accounting professionals serve as an extension of your team, providing transaction processing, month-end close support, and technical accounting guidance for complex situations involving revenue recognition, lease accounting, and stock-based compensation.
Our technology solutions practice helps you implement systems and controls that scale with your organization, and prepare for the heightened scrutiny of being public or pursuing acquisition. We help you select and implement platforms like NetSuite that support your operational requirements.
Whether you’re an early-stage biotech focused on validating your science, a growth-stage company advancing through clinical trials, or preparing for a liquidity event, we’ve structured our services to match your needs. We’ve built deep knowledge of the biotech, pharmaceutical, medical device, and diagnostic sectors through years of focused work with companies like yours.
When you work with BPM, you’re not spending time explaining why clinical trial expenses fluctuate or why your licensing arrangement has unusual terms. This familiarity translates directly into more efficient service delivery, more relevant advice, and financial support that truly enables rather than merely complies with requirements.
Looking for a team who understands where you’re headed and how to help you get there? Whether you’re building something new, managing growth or preserving success, let’s talk.